Sindlev Rene 13D and 13G filings for DANDRIT BIOTECH USA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 4:08 pm Purchase | 2023-08-01 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 14,945,971 20.900% | 1,084,500 (+7.82%) | Filing |
| 2024-01-24 4:08 pm Purchase | 2023-06-26 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 13,861,471 23.300% | 2,830,191 (+25.66%) | Filing |
| 2024-01-24 4:07 pm Purchase | 2023-03-17 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 11,031,280 19.600% | 1,328,472 (+13.69%) | Filing |
| 2024-01-24 4:07 pm Purchase | 2021-09-24 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,702,808 18.600% | 17,557 (+0.18%) | Filing |
| 2024-01-24 4:06 pm Purchase | 2019-09-30 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,685,251 20.900% | 170,114 (+1.79%) | Filing |
| 2024-01-24 4:05 pm Purchase | 2018-12-27 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,515,137 24.200% | 94,268 (+1.00%) | Filing |
| 2024-01-24 4:05 pm Unchanged | 2018-02-16 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,420,869 23.200% | 0 (Unchanged) | Filing |
| 2024-01-24 4:04 pm Purchase | 2017-10-13 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,420,869 48.600% | 250,000 (+2.73%) | Filing |
| 2024-01-24 4:04 pm Purchase | 2017-04-21 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,170,869 51.400% | 8,100,000 (+756.40%) | Filing |
| 2024-01-24 4:03 pm Purchase | 2016-03-14 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 1,070,869 11.200% | 1,070,869 (New Position) | Filing |